SCHEMBL155013

SCHEMBL155013

O=[N+]([O-])c1ccc2[nH]c3ccc([N+](=O)[O-])cc3c2c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.70
GABRG2 P18507 2/20 0.70
GABRB3 P28472 2/20 0.70
GABRA5 P31644 2/20 0.70
GABRA2 P47869 2/20 0.70
CTSV O60911 2/20 0.69
CTSL P07711 2/20 0.69
PARP1 P09874 2/20 0.69
CA12 O43570 2/20 0.68
CA9 Q16790 2/20 0.68
KIF11 P52732 1/20 0.66
MAPT P10636 6/20 0.60
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
LMNA P02545 3/20 0.60
ALDH1A1 P00352 2/20 0.60
POLB P06746 1/20 0.60
PKM P14618 1/20 0.60
NPY1R P25929 1/20 0.60
NPY2R P49146 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29540314 1.00 GABRA1 (0.70) GABRA1GABRG2GABRB3GABRA5GABRA2
SCHEMBL30272741 0.91 CTSV (0.79) GABRA1GABRG2GABRB3GABRA5GABRA2
SCHEMBL151534 0.91 CTSV (0.79) GABRA1GABRG2GABRB3GABRA5GABRA2
SCHEMBL30272743 0.91 CTSV (0.79) GABRA1GABRG2GABRB3GABRA5GABRA2
SCHEMBL30272742 0.91 CTSV (0.79) GABRA1GABRG2GABRB3GABRA5GABRA2
SCHEMBL17396637 0.89 GABRA1 (0.59) GABRA1GABRG2GABRB3GABRA5GABRA2
SCHEMBL20920125 0.89 GABRA1 (0.59) GABRA1GABRG2GABRB3GABRA5GABRA2
SCHEMBL12722533 0.89 MAPT (0.59) GABRA1GABRG2GABRB3GABRA5GABRA2
SCHEMBL30272747 0.89 GABRA1 (0.59) GABRA1GABRG2GABRB3GABRA5GABRA2
SCHEMBL1181214 0.85 CTSV (0.86) GABRA1GABRG2GABRB3GABRA5GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115109600-B Diamine compound and preparation method and application thereof 波米科技有限公司 2023-11-28 CN claimed
CN-113200906-B Carbazole triamine derivative and preparation method and application thereof 南京工业大学 2023-02-17 CN claimed
CN-115109600-A Diamine compound and preparation method and application thereof 波米科技有限公司 2022-09-27 CN claimed
CN-113200906-A Carbazole triamine derivative and preparation method and application thereof 南京工业大学 2021-08-03 CN claimed
EP-1575575-A2 SAFE CHEMICAL UNCOUPLERS FOR THE TREATMENT OF OBESITY NOVO NORDISK A/S (DK) 2005-09-21 EP claimed
US-20040138301-A1 Chemical uncouplers for the treatment of obesity HIGH POINT PHARMACEUTICALS, LLC 2004-07-15 US claimed
WO-2004041256-A2 SAFE CHEMICAL UNCOUPLERS FOR THE TREATMENT OF OBESITY NOVO NORDISK A/S (DK) 2004-05-21 WO claimed
US-20250366298-A1 FUNCTIONAL MATERIAL, PASSIVATION FILM, SOLAR CELL, PHOTOVOLTAIC MODULE, AND PHOTOVOLTAIC SYSTEM CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) 2025-11-27 US disclosed
EP-4624481-A1 FUNCTIONAL MATERIAL, PASSIVATION FILM, SOLAR CELL, PHOTOVOLTAIC MODULE, AND PHOTOVOLTAIC SYSTEM Contemporary Amperex Technology Co., Limited (CN) 2025-10-01 EP disclosed
CN-119569032-A Lithium battery negative electrode material for high temperature and high multiplying power and preparation method thereof 江苏量能动力科技有限公司 2025-03-07 CN disclosed
WO-2024230264-A1 FUNCTIONAL MATERIAL, PASSIVATION FILM, SOLAR CELL, PHOTOVOLTAIC MODULE, AND PHOTOVOLTAIC SYSTEM 宁德时代新能源科技股份有限公司 2024-11-14 WO disclosed
CN-115109600-B Diamine compound and preparation method and application thereof 波米科技有限公司 2023-11-28 CN disclosed
CN-116893465-A optical laminate 住友化学株式会社 2023-10-17 CN disclosed
EP-0037563-B1 SULFUR DYES OF THE CARBAZOLE SERIES, THEIR PREPARATION AND APPLICATION, AS WELL AS INTERMEDIATE COMPOUNDS CASSELLA Aktiengesellschaft (DE) 1984-02-15 EP disclosed
EP-0087690-A1 Process for the preparation of aromatic amines BAYER AG (DE) 1983-09-07 EP disclosed
US-4360459-A Sulphur dyestuffs of the carbazole series CASSELLA AKTIENGESELLSCHAFT (DE) 1982-11-23 US disclosed
US-4310634-A 1-HYDRAZINO-2-HYDRAZONO ETHANE TEXACO DEVELOPMENT CORP. (US) 1982-01-12 US disclosed
EP-0037563-A1 Sulfur dyes of the carbazole series, their preparation and application, as well as intermediate compounds CASSELLA Aktiengesellschaft (DE) 1981-10-14 EP disclosed
US-4286072-A 1-/DIALKYLHYDRAZONO/-2-HYDROXYETHANES; POLYURETHANE-POLYISOCYANURATE FOAMS TEXACO DEVELOPMENT CORP. (US) 1981-08-25 US disclosed
US-4251637-A TO PREPARE A POLYMER CONTAINING RECURRING ISOCYANURATE AND URETHANE LINKAGES TEXACO DEVELOPMENT CORPORATION (US) 1981-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250366298-A1 FUNCTIONAL MATERIAL, PASSIVATION FILM, SOLAR CELL, PHOTOVOLTAIC MODULE, AND PHOTOVOLTAIC SYSTEM RAD1, CRY1, C1S GABRA1 3075/4885GABRG2 3912/4885GABRB3 4068/4885
US-20040138301-A1 Chemical uncouplers for the treatment of obesity PC, CPT2, IDH2 GABRA1 3854/4885GABRG2 2289/4885GABRB3 3006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.